The latest technique has a proven higher recovery rate for artery blockages and being dissolvable, it allows for further procedures to be done with ease without too many complications.
Blockage in arteries is a commonly diagnosed heart disease which if left untreated, can lead to heart attacks.
UAE, xx September, 2020: A 32-year-old Southeast Asian male patient, diagnosed with Discrete Coronary Stenosis, a blockage in the arteries of the heart, was treated at Aster Hospital, Mankhool using a bio-absorbable and self-dissolving scaffold called “Magmaris”, one of the latest stent innovations in the field of Cardiology.
Discrete Coronary Stenosis is a short segment blockage in the arteries of the heart due to presence of a lesion of size less than 10mm. This abnormality can be caused due to, but not limited to a number of factors such as high cholesterol, smoking, etc. *As per a study conducted by Aster Hospitals in 2018, this blockage is seen to develop earlier in age amongst Southeast Asian patients as compared to patients from the West.
A patient of Aster Clinics, Dubai was referred to Dr Naveed Ahmed, Specialist Interventional Cardiologist at Aster Hospital, Mankhool. At the time of admission, the patient was experiencing chest pains and discomfort for a few days before arriving at the hospital. He had a past history of smoking and hypertension for the last one year.
His reports sent from Aster Clinics along with tests and an angiogram conducted at the hospital, showed that the patient was suffering from severe 90% Discrete Coronary Stenosis. This indicated that he had a 90% blockage in one of the 3 major arteries of the heart. Further tests conducted, showed a 3.5mm non-branched lesion which qualified him for treatment using a bio-absorbable stent to fix the artery blockage in his heart.
Dr Naveed Ahmed, Specialist Interventional Cardiologist, lead doctor of the case added, “We have used one of the latest innovations in cardiac stents called ‘Magmaris’ a self-dissolving stent for the procedure. Patients suffering from Coronary Stenosis usually require procedures to be done throughout their lifetime and the younger the patient is, the more procedures they will need. Keeping in mind the age of the patient, we have used this particular stent as it will dissolve within one year of the surgery allowing for more procedures to be performed in future, without any complications.”
Dr Sherbaz Bichu, CEO Aster Hospitals and Clinics stated, “Patient safety and welfare is key at Aster Hospitals. Our aim is to provide the best procedures to our patients that allow them to have a good quality of life in the long run. We are constantly upgrading our procedures and technologies used, so that optimum solutions can be offered to our patients with quicker recovery and fewer complications.”
The stent used in the procedure has been proven to have better recovery rates as compared to its predecessors. Post-surgery, an Angiogram showed good results of the artery blood flow. The patient was discharged the next day with recommendation of close follow-ups.
Aster Hospitals, UAE is Aster DM Healthcare’s continuation of its endeavor to create world-class, patient-centric hospitals driven by medical innovations and a culture of excellence. The Hospital aims to make a difference, with its patient-centric approach to medical care. The state-of-the-art multispecialty hospital in Mankhool is a 100-bedded medical facility, and Al Qusais a 150-bedded facility, where doctors adopt a multidisciplinary approach to provide holistic treatment to patients. Equipped with the most advanced Neonatal Intensive Care Unit in UAE, Aster Hospital offers multispecialty medical and surgical care all under one roof. Aster Hospitals has recently also added a hospital under the name ‘Aster Cedars Hospital’ and a 50-bedded facility in Muhaisnah under its banner.
Aster DM Healthcare Limited is one of the largest private healthcare service providers operating in multiple GCC states and is an emerging healthcare player in India. With an inherent emphasis on clinical excellence, we are one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare through our hospitals, and clinics. We have over 20,000 plus dedicated employees across the geographies that we are present in, delivering a simple yet strong promise to our different stakeholders: “We’ll treat you well.” We reach out to all economic segments in the GCC states through our differentiated healthcare services across the “Aster”, “Medcare” and “Access” brands.